Helixate NexGen

Medicinal product

(Invented) name

Helixate NexGen

Active substance (s)

Žmogaus VIII (rDNR) koaguliacijos faktorius

Strength

250 TV

Pharmaceutical form

milteliai ir tirpiklis injekciniam tirpalui

Route (s) of administration

leisti į veną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

B02BD02, Coagulation factor VIII

Marketing authorisation holder

Bayer AG, Vokietija

Date of authorisation

2000-08-04

Date of renewal

Documents

Search in EMA Europe

Stage

Išregistruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Powder and solvent for solution for injection	1 vnt.
Žmogaus VIII (rDNR) koaguliacijos faktorius	250 TV

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
26173	28762	1028762	flakonas	N1 (+1 flakonas tirpiklio + 1 perpylimo filtras + 1 venepunkcijos rinkinys + 1 švirkštas + 2 tamponai)		Receptinis	EU/1/00/144/001	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2019-12-16	Išregistruotas
2000-08-04	Registruotas